Seagen Inc. (SGEN)
NASDAQ: SGEN
· Real-Time Price · USD
228.74
-0.16 (-0.07%)
At close: Dec 13, 2023, 10:00 PM
Seagen Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|
| Product Revenue | 1.71B | 1.39B | 1B | 150.25M | 58.6M |
| Product Revenue Growth | +23.16% | +38.47% | +565.98% | +156.37% | n/a |
| License and Service Revenue | 91.34M | 38.28M | 1.05B | 627.98M | 476.9M |
| License and Service Revenue Growth | +138.60% | -96.35% | +66.91% | +31.68% | n/a |
| Royalty Revenue | 164.55M | 150.52M | 126.76M | 138.49M | n/a |
| Royalty Revenue Growth | +9.32% | +18.75% | -8.47% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 265.69M | 243.93M | 236.44M | 216.1M | 210.38M | 220.26M | 174.22M | 210.94M | 180.28M | 165.13M | 159.84M | 158.37M | 127.58M | 125.64M | 122.25M | 115.23M | 96.1M | 82.33M | 80.27M | 79.47M | 57.16M | 58.29M | 66.18M | 48.45M | 39.67M | 40.71M | 38.4M | 41.38M | 34.84M | 33.28M | 29.75M | 33.63M | 29.68M | 30.34M | 32.12M |
| Selling, General, and Administrative Revenue Growth | +8.92% | +3.17% | +9.41% | +2.72% | -4.49% | +26.42% | -17.40% | +17.00% | +9.18% | +3.31% | +0.93% | +24.13% | +1.54% | +2.78% | +6.09% | +19.90% | +16.73% | +2.57% | +1.01% | +39.04% | -1.95% | -11.92% | +36.60% | +22.14% | -2.57% | +6.01% | -7.19% | +18.76% | +4.68% | +11.88% | -11.56% | +13.31% | -2.17% | -5.54% | n/a |
| Research and Development Revenue | 449.05M | 399.87M | 356.01M | 357.84M | 384.61M | 304.25M | 297.66M | 304.29M | 459.09M | 234.86M | 230.43M | 216.18M | 217.67M | 198.08M | 195.2M | 201.06M | 196.12M | 163.93M | 158.26M | 149.77M | 140.18M | 122.86M | 152.5M | 110.5M | 113.61M | 114.41M | 118.18M | 108.17M | 92.71M | 85.55M | 92.87M | 74.61M | 70.79M | 85.74M | 63.4M |
| Research and Development Revenue Growth | +12.30% | +12.32% | -0.51% | -6.96% | +26.41% | +2.22% | -2.18% | -33.72% | +95.47% | +1.92% | +6.59% | -0.68% | +9.89% | +1.47% | -2.92% | +2.52% | +19.64% | +3.58% | +5.67% | +6.85% | +14.09% | -19.44% | +38.01% | -2.73% | -0.70% | -3.20% | +9.26% | +16.68% | +8.37% | -7.88% | +24.48% | +5.39% | -17.43% | +35.24% | n/a |